ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

ME9 Boosting immunotherapy in lung cancer

Meet the expert
Aims: Access educational materials here
Immunotherapy has already developed to a new life-prolonging therapeutic backbone in advanced non-small cell lung cancer with significantly life-prolonging checkpoint-inhibitors available not only for second line but also first line therapy in routine care. The aim of this session is to provide a most current and comprehensive update as well as a future perspective on the advanced use of established and new immunotherapeutic drugs in lung cancer. The emphasis is on the combination of immunotherapeutic drugs with present treatment modalities such as other systemic therapies or radiotherapy since these seem to bear the potential to booster immunotherapy.

Download all media

Boosting immunotherapy in lung cancer J. Cadranel (Paris, France)